|
|
Blood, 1 March 2006, Vol. 107, No. 5, pp. 2037-2044.
Prepublished online as a Blood First Edition Paper on November 17, 2005; DOI 10.1182/blood-2005-07-2760.
Previous Article | Next Article 
Submitted July 12, 2005
Accepted October 19, 2005
GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response
Nicolas Cohen, Enguerran Mouly, Haifa Hamdi, Marie-Christine Maillot, Marc Pallardy, Veronique Godot, Francis Capel, Axel Balian, Sylvie Naveau, Pierre Galanaud, Francois M Lemoine, and Dominique Emilie*
INSERM UMR-S131, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France
CNRS UMR 7087/UPMC, Hopital Pitie-Salpetriere, Assistance Publique-Hopitaux de Paris, Paris, France
INSERM UMR-S 461, Faculte de Pharmacie, Universite Paris-Sud, Chatenay-Malabry, France
INSERM UMR-S131, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France; Service d'Hepato-Gastro-Enterologie, Hopital Antoine Beclere, Assistance Publique- Hopitaux de Paris, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France
INSERM UMR-S131, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France; Service de Microbiologie-Immunologie biologique, Hopital Antoine Beclere, Assistance Publique- Hopitaux de Paris, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France
* Corresponding author; email: emilie{at}ipsc.u-psud.fr.
Interleukin (IL)-10 and glucocorticoids (GC) inhibit the ability of antigen-presenting dendritic cells (DC) to stimulate T lymphocytes. We show that induction of GILZ (Glucocorticoid-Induced Leucine Zipper) is involved in this phenomenon. IL-10, dexamethasone (DEX) and transforming growth factor (TGF) stimulate GILZ production in human DC derived from monocytes and from CD34+ cells. GILZ is necessary and sufficient for DEX, IL-10 and TGF modulation of CD80, CD83, CD86, ILT3 and B7-H1 expression by DC and alteration of DC functions. GILZ stimulates the production of IL-10 by immature DC and it prevents the production of inflammatory chemokines by CD40L-activated DC. In contrast, GILZ has no effect on CD40L-mediated inhibition of phagocytosis, indicating that it affects some but not all aspects of DC maturation. GILZ also prevents DC from activating antigen-specific T lymphocyte responses. Administration of GC to patients stimulates GILZ expression in their circulating antigen-presenting cells, and this contributes to the weak lymphocyte responses of GC-treated patients. Thus, regulation of GILZ expression is an important factor determining the decision of DC whether or not to stimulate T lymphocytes, and IL-10, GC and TGF share this mechanism for influencing DC functions and the balance between immune response and tolerance.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Ayroldi and C. Riccardi
Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action
FASEB J,
November 1, 2009;
23(11):
3649 - 3658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chamorro, J. J. Garcia-Vallejo, W. W. J. Unger, R. J. Fernandes, S. C. M. Bruijns, S. Laban, B. O. Roep, B. A. 't Hart, and Y. van Kooyk
TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program
J. Immunol.,
September 1, 2009;
183(5):
2984 - 2994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brenk, M. Scheler, S. Koch, J. Neumann, O. Takikawa, G. Hacker, T. Bieber, and D. von Bubnoff
Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells
J. Immunol.,
July 1, 2009;
183(1):
145 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Terness, T. Oelert, S. Ehser, J. J. Chuang, I. Lahdou, C. Kleist, F. Velten, G. J. Hammerling, B. Arnold, and G. Opelz
Mitomycin C-treated dendritic cells inactivate autoreactive T cells: Toward the development of a tolerogenic vaccine in autoimmune diseases
PNAS,
November 25, 2008;
105(47):
18442 - 18447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hamdi, V. Godot, M.-C. Maillot, M. V. Prejean, N. Cohen, R. Krzysiek, F. M. Lemoine, W. Zou, and D. Emilie
Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper
Blood,
July 1, 2007;
110(1):
211 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Raja Gabaglia, Y. Diaz de Durana, F. L. Graham, J. Gauldie, E. E. Sercarz, and T. A. Braciak
Attenuation of the Glucocorticoid Response during Ad5IL-12 Adenovirus Vector Treatment Enhances Natural Killer Cell-Mediated Killing of MHC Class I-Negative LNCaP Prostate Tumors
Cancer Res.,
March 1, 2007;
67(5):
2290 - 2297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Shi, K. Luo, D. Xia, T. Chen, G. Chen, Y. Jiang, N. Li, and X. Cao
DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cell-initiated antigen-specific T-cell responses
Blood,
October 15, 2006;
108(8):
2678 - 2686.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|